Fulgent Genetics (FLGT) Enterprise Value (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Enterprise Value for 11 consecutive years, with -$341.4 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 30.2% to -$341.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$341.4 million through Dec 2025, down 30.2% year-over-year, with the annual reading at -$341.4 million for FY2025, 30.2% down from the prior year.
- Enterprise Value hit -$341.4 million in Q4 2025 for Fulgent Genetics, up from -$380.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$216.6 million in Q3 2024 to a low of -$578.3 million in Q1 2022.
- Historically, Enterprise Value has averaged -$401.3 million across 5 years, with a median of -$415.1 million in 2021.
- Biggest five-year swings in Enterprise Value: crashed 1692.82% in 2021 and later skyrocketed 53.38% in 2024.
- Year by year, Enterprise Value stood at -$443.4 million in 2021, then decreased by 17.97% to -$523.0 million in 2022, then rose by 18.37% to -$427.0 million in 2023, then soared by 38.6% to -$262.2 million in 2024, then tumbled by 30.2% to -$341.4 million in 2025.
- Business Quant data shows Enterprise Value for FLGT at -$341.4 million in Q4 2025, -$380.9 million in Q3 2025, and -$297.9 million in Q2 2025.